Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.40 |
| ▸ | ADH1C | P00326 | 1/20 | 0.40 |
| ▸ | ADH1A | P07327 | 1/20 | 0.40 |
| ▸ | ADH4 | P08319 | 1/20 | 0.40 |
| ▸ | ADH7 | P40394 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL102497 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL103308 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL201001 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL199750 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL102914 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL101878 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL7888892 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL7939027 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL103793 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR | |
| SCHEMBL199645 | 1.00 | ACE2 (0.48) | ACE2OPRM1SPHK1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024018761-A1 | NEUTRAL LIPID AND LIPID NANOPARTICLE | 国立大学法人北海道大学 | 2024-01-25 | — | — | WO | disclosed |
| WO-2024018762-A1 | PH-SENSITIVE CATIONIC LIPID AND LIPID NANOPARTICLE | 国立大学法人北海道大学 | 2024-01-25 | — | — | WO | disclosed |
| CN-110235956-B | Oil additive, oil composition containing same, and method for producing same | 丰益(上海)生物技术研发中心有限公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-110235956-A | Grease additive, fat or oil composition and its manufacturing method comprising it | 丰益(上海)生物技术研发中心有限公司 | 2019-09-17 | — | — | CN | disclosed |
| CN-103068786-B | Cosmetic preparation | COGNIS IP MANAGEMENT GMBH (DE) | 2016-01-20 | — | — | CN | disclosed |
| US-8940943-B2 | Cosmetic preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2015-01-27 | — | — | US | disclosed |
| EP-2601166-A1 | COSMETIC PREPARATIONS | Cognis IP Management GmbH (DE) | 2013-06-12 | — | — | EP | disclosed |
| US-20130131188-A1 | Cosmetic Preparations | COGNIS IP MANAGEMENT GMBH (DE) | 2013-05-23 | — | — | US | disclosed |
| CN-103068786-A | Cosmetic preparation | COGNIS IP MAN GMBH | 2013-04-24 | — | — | CN | disclosed |
| EP-2426101-A1 | Cosmetic preparations | Cognis IP Management GmbH (DE) | 2012-03-07 | — | — | EP | disclosed |
| US-8114819-B2 | Polymers for oilfield applications | BAKER HUGHES INCORPORATED (US) | 2012-02-14 | — | — | US | disclosed |
| WO-2012016642-A1 | COSMETIC PREPARATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2012-02-09 | — | — | WO | disclosed |
| US-20100105580-A1 | Polymers For Oilfield Applications | BJ SERVICES COMPANY (US) | 2010-04-29 | — | — | US | disclosed |
| EP-2009074-A1 | VISCOSITY INDEX IMPROVER AND LUBRICANT COMPOSITION | Sanyo Chemical Industries, Ltd. (JP) | 2008-12-31 | — | — | EP | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
| US-20040242440-A1 | Metal working fluid composition for use as spray in mist form | IDEMITSU KOSAN CO., LTD. (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-0739970-B1 | Gas oil compositions and gas oil additives | KAO CORP (JP) | 2003-03-19 | — | — | EP | disclosed |
| US-5855628-A | LOW SULFUR, MIXTURE OF MONOGLYCERIDE AND DIGLYCERIDE | KAO CORPORATION (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0739970-A1 | Gas oil compositions and gas oil additives | KAO CORPORATION (JP) | 1996-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131188-A1 | Cosmetic Preparations | CYP1B1, CBR1, ACOX3 | ACE2 3825/4885OPRM1 745/4885SPHK1 1590/4885 |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | CARM1, CPN1, CCNT1 | ACE2 710/4885OPRM1 290/4885SPHK1 3958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.